Journal Mobile Options
Table of Contents
Vol. 33, No. 11, 2010
Issue release date: November 2010
Add to my selection Citation Download
Onkologie 2010;33:613–615
(DOI:10.1159/000321126)
Case Report · Kasuistik

Giant Basal Cell Carcinoma of the Breast Mimicking Paget’s Disease: Complete Remission after Photodynamic Therapy

Mikhaimer N.C.a · Kähler K.C.a · Schwarz T.a · Mundhenke C.b · Hauschild A.a
aKlinik für Dermatologie, Venerologie und Allergologie, bKlinik für Gynäkologie und Geburtshilfe, Mammazentrum, Campus Kiel, Universitätsklinikum Schleswig-Holstein, Kiel, Germany Onkologie 2010;33:613–615 (DOI:10.1159/000321126)

Abstract

Background: Basal cell carcinoma (BCC) in the nipple area is extremely rare and can be mistaken for Paget’s disease. Case Report: A 47-year-old woman complained of a slowly growing, scaly erythematous plaque around her right nipple which had developed over several years. Paget’s disease of the breast was suspected. Biopsies revealed a superficial BCC. The maximum tumor thickness was measured as 1 mm. Considering the superficial character of the tumor, photodynamic therapy (PDT) as a non-invasive approach was performed. Complete remission (CR) with an excellent cosmetic result was achieved after 4 PDT sessions. In the follow-up, CR with no signs of a local recurrence was evident after more than 24 months. Conclusion: In similar superficial cases of BCCs, non-invasive procedures such as PDT can be discussed as an alternative option to radical surgery or radiotherapy, with an excellent aesthetic outcome in carefully selected cases.

 goto top of outline Author Contacts

Dr. med. Nadia C. Mikhaimer, Klinik für Dermatologie, Venerologie und Allergologie, Campus Kiel, Universitätsklinikum Schleswig-Holstein, Schittenhelmstr. 7, 24105 Kiel, Germany, Tel. +49 431 597-1512, Fax -1853, NMikhaimer@dermatology.uni-kiel.de


 goto top of outline Article Information

Published online: October 15, 2010
Number of Print Pages : 3


 goto top of outline Publication Details

Onkologie (International Journal for Cancer Research and Treatment)

Vol. 33, No. 11, Year 2010 (Cover Date: October 2010)

Journal Editor: Schmoll H.-J. (Halle/Saale)
ISSN: 0378-584X (Print), eISSN: 1423-0240 (Online)

For additional information: http://www.karger.com/ONK


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.